Review



antibodies against vp5  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc antibodies against vp5
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Antibodies Against Vp5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against vp5/product/Cell Signaling Technology Inc
    Average 94 stars, based on 18 article reviews
    antibodies against vp5 - by Bioz Stars, 2026-06
    94/100 stars

    Images

    1) Product Images from "Novel Hsp90 inhibitor JD-02 inhibits HSV-1 infection via the Raf/MEK/ERK signaling pathway"

    Article Title: Novel Hsp90 inhibitor JD-02 inhibits HSV-1 infection via the Raf/MEK/ERK signaling pathway

    Journal: International Journal of Molecular Medicine

    doi: 10.3892/ijmm.2026.5810

    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein VP5 (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Figure Legend Snippet: JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein VP5 (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.

    Techniques Used: Infection, Western Blot, Viral Plaque Assay, Immunofluorescence, Virus



    Similar Products

    antibodies against vp5  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc antibodies against vp5
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Antibodies Against Vp5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against vp5/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    antibodies against vp5 - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier
    rad23b  (Proteintech)
    93
    Proteintech rad23b
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Rad23b, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rad23b/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rad23b - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    anti rad23b  (Proteintech)
    93
    Proteintech anti rad23b
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Anti Rad23b, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rad23b/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti rad23b - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    rad23b sirnas sc60812  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology rad23b sirnas sc60812
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Rad23b Sirnas Sc60812, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rad23b sirnas sc60812/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    rad23b sirnas sc60812 - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    rad23b  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc rad23b
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Rad23b, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rad23b/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    rad23b - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier
    rad23b  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology rad23b
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    Rad23b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rad23b/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    rad23b - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    137088 rrid ab 2300766  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology 137088 rrid ab 2300766
    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein <t>VP5</t> (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.
    137088 Rrid Ab 2300766, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/137088 rrid ab 2300766/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    137088 rrid ab 2300766 - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein VP5 (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.

    Journal: International Journal of Molecular Medicine

    Article Title: Novel Hsp90 inhibitor JD-02 inhibits HSV-1 infection via the Raf/MEK/ERK signaling pathway

    doi: 10.3892/ijmm.2026.5810

    Figure Lengend Snippet: JD-02 inhibits HSV-1 early infection. (A) Schematic representation of the time-of-addition assay. (B) Western blot analysis of viral proteins (gB, ICP0, gD and ICP27) from HaCaT cells infected with HSV-1 and treated with JD-02 (0.5 μ M) for indicated time. (C) The DNA copy number of UL54 from HaCaT cells with HSV-1 infection and treated with JD-02. (D-F) Viral plaque assay detecting JD-02 effect on (D) viral inactivation, (E) viral attachment and (F) viral penetration. (G) Immunofluorescence analysis of the distribution of the viral protein VP5 (green) within the cytoplasm and nucleus (DAPI, blue). Scale bar, 10 μ m. Data are presented as the mean ± SD (n=3). * P<0.05 and ** P<0.01 compared with the HSV-1 group. HSV, Herpes Simplex Virus; ns, not significant.

    Article Snippet: Antibodies against GAPDH (cat. no. GTX100118) were purchased from GeneTex, Inc. Antibodies against phospho-ERK1/2 (cat. no. 4370S), ERK1/2 (cat. no. 4695S), phospho-MEK1/2 (cat. no. 9154T), phospho-B-Raf (cat. no. 2696T), HA (cat. no. 3724S) and Flag (cat. no. 14793S) were obtained from Cell Signaling Technology, Inc. Antibodies against VP5 (cat. no. sc-13525), gB (cat. no. sc-56987) and Raf-B (C-19) (cat. no. sc-166) were obtained from Santa Cruz Biotechnology, Inc. Antibodies against MEK1/2 (cat. no. AF6385) were obtained from Affinity Biosciences.

    Techniques: Infection, Western Blot, Viral Plaque Assay, Immunofluorescence, Virus